stocksINDOUS
64.99-2.9 (-4.29%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Indo US Bio-Tech Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2017201820192020202120222023202420252026
Annual ReportsFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results——
Conference Calls——————————
Presentations——————————

Corporate Announcements and Regulatory Filings

Indo US Bio-Tech Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Board Meeting24 Oct 2026
    Board Meeting Intimation for Considering, Approving And Take On Record The Un-Audited Standalone Financial Result Of The Company For The Quarter And Half Year Ended 30Th September, 2026.
    Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve and take on record the Un-Audited ....
  2. General23 Oct 2026
    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Directors Cum Promoters And Other Promoter Visit To China.
    Directors cum promoters and other promoter visit china
  3. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201814 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Regulation 74(5) of SEBI DP Regulation Certificate received from RTA.
  4. AGM2 Oct 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Voting Results and Scrutinizer''s Report for passing resolutions through remote e voting in 22nd AGM of the Company
  5. AGM30 Sept 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Pursuant to regulation 30 of SEBI LODR Regulations, we here by enclose a gist of proceedings of 22nd AGM held on Wednesday 30th September, 2026. Request you to take the same on the record ....
  6. Closure of Trading Window28 Sept 2026
    Closure of Trading Window
    Closure of Trading Window
  7. Newspaper Publication6 Sept 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Notice of 22nd AGM of the company to be held 30th September, 2026 through VC/OCAM published in Newspaper.
  8. Reg. 34 (1) Annual Report5 Sept 2026
    Reg. 34 (1) Annual Report.
    Annual Report 2025-26
  9. AGM5 Sept 2026
    Intimation Of Book Closure For The Purpose Of 22Nd AGM Pursuant To Regulation 42 Of SEBI (LODR)
    Book closure period from 23rd September, 2026 to 30th September, 2026 (Both inclusive days) for the purpose of 22nd AGM of the company to be held on 30th Sep, 2026.
  10. AGM5 Sept 2026
    Shareholder Meeting- AGM On Sep 30, 2026
    AGM to be held on Wednesday 30-09-2026 at 02:30 pm through VC/OCAM.
  11. Outcome without intimation5 Sept 2026
    Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday, 05Th September, 2026.
    The Board met today, discussed and resolved the agendas mentioned in attachment & attached Annexure A Book Closure Date (both days inclusive).
  12. Newspaper Publication13 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Submitting Newspaper Advertisement relating to the Unaudited Quarterly Standalone Financial Results for the quarter ended on 30th June, 2026.
  13. Outcome of Board Meeting12 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On August 12, 2026, Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
    Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company at their meeting ....
  14. Postal Ballot5 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    Proceedings
  15. Postal Ballot5 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Postal Ballot Results by remove e voting process and Scrutinizer''s Report.
  16. Board Meeting4 Aug 2026
    Board Meeting Intimation for (A) The Unaudited Financial Results For The Quarter Ended On June 30, 2026, Pursuant To Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015;
    Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve (a) The Unaudited Financial ....
  17. General15 Jul 2026
    Revised Outcome Of The Board Meeting Held On 10 July 2026.
    Committee Composition approved in the Outcome of Board Meeting dated 10th July, 2026 shall be read as effective from 21st April, 2026, being the effective date of the Appointment and resignation ....
  18. General15 Jul 2026
    Revised: Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015. Ref.: Mail From Query.Lodr@Bseindia.Com On 13.07.2026 Subject: Resignation Of Statutory Auditor And Appointment Of New Statutory Auditor. Resubmitting The Details As Per Attached SEBI Circular Dated October 18, 2019, Through BSE Listing Centre.
    Revised announcement submit.
  19. Outcome without intimation10 Jul 2026
    Board Meeting Outcome for Change In Composition Of Committees Of The Board.
    Pursuant to the resignation of Mrs. Nehaben Patel (DIN: 09263180) from the office of Non-Executive Independent Director of the Company, the Board of Directors, at its meeting held on 21st ....
  20. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI DP Regulation for the quarter ended on 30th June, 2026

Frequently Asked Questions

Where can I download the annual report of Indo US Bio-Tech Ltd.?
Annual reports of Indo US Bio-Tech Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Indo US Bio-Tech Ltd.?
Quarterly earnings results and presentations of Indo US Bio-Tech Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Indo US Bio-Tech Ltd. publish earnings call transcripts?
Earnings call transcripts of Indo US Bio-Tech Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Indo US Bio-Tech Ltd.?
Investor presentations and annual day presentations of Indo US Bio-Tech Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Indo US Bio-Tech Ltd.?
Corporate announcements and regulatory filings of Indo US Bio-Tech Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Indo US Bio-Tech Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Indo US Bio-Tech Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Indo US Bio-Tech Ltd.?
The ISIN (International Securities Identification Number) of Indo US Bio-Tech Ltd. is INE250Z01010. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Indo US Bio-Tech Ltd. listed?
Indo US Bio-Tech Ltd. is listed on NSE and BSE. The NSE symbol is INDOUS and the BSE code is -.
Where can I find the shareholding pattern of Indo US Bio-Tech Ltd.?
The quarterly shareholding pattern of Indo US Bio-Tech Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Indo US Bio-Tech Ltd. on Sharpely?
Share price data for Indo US Bio-Tech Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.